Quick Answer
ACHIEVE LIFE SCIENCES, INC. reported Net Income of -$54.65 million for fiscal year 2025.
ACHIEVE LIFE SCIENCES, INC. — Key Financials by Year
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|
| Net Income | -$54.65M -37.2% |
-$39.83M -33.6% |
-$29.82M +29.6% |
-$42.35M -27.7% |
-$33.15M -125.1% |
-$14.73M +10.2% |
| Diluted EPS | -$1.25 -0.8% |
-$1.24 +17.3% |
-$1.50 +62.5% |
-$4.00 +2.0% |
-$4.08 +24.7% |
-$5.42 |
| Total Assets | $41.79M +8.2% |
$38.63M +99.4% |
$19.37M -35.4% |
$29.97M -36.9% |
$47.52M +17.9% |
$40.30M +91.2% |
| Cash and Equivalents | $20.93M +64.1% |
$12.75M -18.0% |
$15.55M -37.2% |
$24.77M -42.4% |
$43.02M +20.0% |
$35.85M +115.2% |
| Stockholders Equity | $21.52M +3.0% |
$20.90M +1543.3% |
-$1.45M -117.4% |
$8.30M -70.4% |
$28.04M -24.8% |
$37.29M +106.6% |
| R&D Expense | — | $22.82M +44.3% |
$15.81M -47.4% |
$30.08M +25.5% |
$23.97M +248.2% |
$6.88M -28.9% |
| Shares Outstanding | 53.23M +53.5% |
34.69M +63.9% |
21.17M +18.3% |
17.90M +89.3% |
9.45M +54.7% |
6.11M +314.6% |
Most Recent Quarter
| Metric | Quarter Ending | Value | YoY | QoQ |
|---|---|---|---|---|
| Net Income | September 30, 2025 | -$14.44M | -15.4% | -13.5% |
| Diluted EPS | September 30, 2025 | -$0.28 | +22.2% | +24.3% |
| Total Assets | September 30, 2025 | $52.04M | +8.6% | -11.7% |
| Cash and Equivalents | September 30, 2025 | $31.93M | +234.6% | -38.4% |
| Stockholders Equity | September 30, 2025 | $33.62M | +7.1% | -19.3% |
| R&D Expense | September 30, 2025 | $5.32M | -30.1% | -20.7% |
| Operating Income | September 30, 2012 | $8.29M | +102.3% | +39.5% |
| Shares Outstanding | September 30, 2025 | 52.81M | +53.6% | +6.3% |
- ACHIEVE LIFE SCIENCES, INC. reported Net Income of -$54.65 million for fiscal year 2025.
- ACHIEVE LIFE SCIENCES, INC. showed a decrease of -37.2% in Net Income compared to the prior fiscal year.
- ACHIEVE LIFE SCIENCES, INC. reported Diluted EPS of $1.25 per share (loss) for fiscal year 2025.
- ACHIEVE LIFE SCIENCES, INC. showed a decrease of -0.8% in Diluted EPS compared to the prior fiscal year.
- ACHIEVE LIFE SCIENCES, INC. reported Total Assets of $41.79 million for fiscal year 2025.
- ACHIEVE LIFE SCIENCES, INC. showed an increase of +8.2% in Total Assets compared to the prior fiscal year.
- ACHIEVE LIFE SCIENCES, INC. reported Cash and Equivalents of $20.93 million for fiscal year 2025.
- ACHIEVE LIFE SCIENCES, INC. showed an increase of +64.1% in Cash and Equivalents compared to the prior fiscal year.
- ACHIEVE LIFE SCIENCES, INC. reported Stockholders Equity of $21.52 million for fiscal year 2025.
- ACHIEVE LIFE SCIENCES, INC. showed an increase of +3.0% in Stockholders Equity compared to the prior fiscal year.
- ACHIEVE LIFE SCIENCES, INC. reported R&D Expense of $22.82 million for fiscal year 2024.
- ACHIEVE LIFE SCIENCES, INC. showed an increase of +44.3% in R&D Expense compared to the prior fiscal year.
- ACHIEVE LIFE SCIENCES, INC. reported Shares Outstanding of 53.23 million shares for fiscal year 2025.
- ACHIEVE LIFE SCIENCES, INC. showed an increase of +53.5% in Shares Outstanding compared to the prior fiscal year.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: